MCALLEN, Texas, June 13, 2016 (SEND2PRESS NEWSWIRE) — Gamma Medical Research, Inc., headed by Dr. Roberto Mangoo-Karim, is excited to announce the licensing of My Doctors Chat to provide Telemedicine in its clinical research programs. Gamma Medical Research, a company dedicated to compassionate medical care and scientific progress, is advancing science and innovation through clinical investigation by conducting pharmaceutical research trials.
My Doctors Chat will serve two functions in our ongoing clinical research programs, states Dr. Mangoo-Karim: One, improving access for those participating in clinical trials and two, improving documentation of any unusual or adverse events patients experience so that it can be recorded as part of the study. My Doctors Chat telemedicine solution offers great potential as an archived video is stored for review at a later date; this makes so much sense for us to be able to review the ongoing effects of clinical research with our participants.
It’s a tremendous opportunity for My Doctors Chat to aid in providing more efficient documentation inside the field of clinical research, states Miguel Esparza Jr., CTO and cofounder of MHIT Business Services Inc., the parent company of My Doctors Chat. Licensing our technology bundle to healthcare organizations allows healthcare organizations and physician organizations to offer telemedicine directly to their patients, he stated.
My Doctors Chat (mydoctorschat.com) is a Fully Scalable Enterprise Telemedicine Mobile Software Solution that is a Customizable HIPAA Compliant Mobile Software Application for Doctors, Patients and Healthcare Organizations using IPhones, IPads as well as Android mobile devices.
Roberto Mangoo-Karim, MD, PhD, FACP, FASN is Adjunct Assistant Professor of Medicine at University of Texas Health Science Center San Antonio/RAHC; Nephrology Coordinator Internal Medicine Residency Program at Doctors Hospital at Renaissance/UTHSCSA; Adjunct Assistant Professor of Medicine at Baylor College of Medicine in Houston, Texas; Preceptor of the Physician Assistant Program and Nurse Practitioner Program at the University of Texas–Pan American College of Health and Human Services in Edinburg, Texas; and Adjunct Faculty at the University of Texas Family Practice Residency Program in McAllen, Texas. He is board certified in Internal Medicine and Nephrology.
After receiving his MD from the Instituto Tecnologico y de Estudios Superiores de Monterrey in Monterrey, Mexico, Dr Mangoo-Karim obtained his PhD in Pharmacology at the University of Kansas Medical Center in Kansas City. He pioneered basic research on the pathophysiology of renal cystic disease. American Journal of Physiology, Journal of Clinical Pharmacology and Journal of the American Society of Nephrology.
Dr. Mangoo-Karim is a member of the American Society of Nephrology, Texas Medical Association, and Hidalgo County Medical Society.
More information on Gamma Medical Research, Inc.: http://gammamedicalresearch.com/.
More information on My Doctors Chat from MHIT Business Services, Inc.: http://mydoctorschat.com/.
Gamma Medical Research, Inc.